Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,297 | -2,089 | -31,431 | -29,335 | -25,314 |
| Depreciation Amortization | 132 | 66 | 580 | 245 | 166 |
| Accounts receivable | 132 | 17 | -112 | -295 | 139 |
| Other Working Capital | 1,834 | 1,338 | 1,532 | 1,666 | 174 |
| Other Operating Activity | 740 | 196 | 20,107 | 20,157 | 19,170 |
| Operating Cash Flow | $-1,459 | $-472 | $-9,324 | $-7,562 | $-5,665 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 759 | 3,104 | 1,470 |
| PPE Investments | -2 | -2 | -18 | -31 | -31 |
| Net Acquisitions | N/A | N/A | -305 | -305 | -305 |
| Other Investing Activity | 1 | 1 | 0 | 0 | 0 |
| Investing Cash Flow | $-1 | $-1 | $436 | $2,768 | $1,134 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 400 | 625 | 400 |
| Debt Repayment | N/A | N/A | -639 | -639 | -639 |
| Common Stock Issued | 14 | N/A | 15 | 15 | 15 |
| Other Financing Activity | 0 | 0 | 2,444 | 2,444 | 2,444 |
| Financing Cash Flow | $14 | $N/A | $2,220 | $2,445 | $2,220 |
| Beginning Cash Position | 2,677 | 2,679 | 9,345 | 2,582 | 2,582 |
| End Cash Position | 1,231 | 2,206 | 2,677 | 233 | 271 |
| Net Cash Flow | $-1,446 | $-473 | $-6,668 | $-2,349 | $-2,311 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,459 | -472 | -9,324 | -7,562 | -5,665 |
| Capital Expenditure | -2 | -2 | -31 | -31 | -31 |
| Free Cash Flow | -1,461 | -474 | -9,355 | -7,593 | -5,696 |